We have shown that ARB, compared to KALETRA, significantly contributes to clinical and laboratory improvements, including peripheral oxygen saturation, requiring ICU admissions, duration of hospitalization, chest CT involvements, WBC, and ESR. Source: Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial | BMC Infectious Diseases | Full Text